{
    "Trade/Device Name(s)": [
        "Elecsys Digoxin Immunoassay",
        "Elecsys PreciControl Cardiac II"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K153301",
    "Predicate Device Reference 510(k) Number(s)": [
        "K973112"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KXT",
        "JJY"
    ],
    "Summary Letter Date": "July 6, 2016",
    "Summary Letter Received Date": "March 10, 2016",
    "Submission Date": "November 12, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3320",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Digoxin Test System",
        "Multi-Analyte Control, All Kinds (Assayed)"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Digoxin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Li-Heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Li-Heparin plasma tube with separating gel"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys",
        "cobas e immunoassay analyzers",
        "cobas e 411 analyzer",
        "cobas e 601 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Digoxin Immunoassay and Elecsys PreciControl Cardiac II for quantitative determination and monitoring of digoxin in human serum and plasma.",
    "Indications for Use Summary": "In vitro quantitative determination of digoxin in human serum and plasma to aid in diagnosis, treatment of overdose, and therapeutic monitoring; PreciControl Cardiac II used for quality control of specified immunoassays on Elecsys and cobas e analyzers.",
    "fda_folder": "Toxicology"
}